Prediction of inter-individual variability on the pharmacokinetics of CYP2C8 substrates in human-Reference-Cited by-同舟云学术

Prediction of inter-individual variability on the pharmacokinetics of CYP2C8 substrates in human

Published:2017-12 Issue:6 Volume:32 Page:277-285
ISSN:1347-4367
Container-title:Drug Metabolism and Pharmacokinetics
language:en
Short-container-title:Drug Metabolism and Pharmacokinetics

Author:

Haraya Kenta,Kato Motohiro,Chiba Koji^ORCID,Sugiyama Yuichi

Funder

Chugai Pharmaceutical Co., Ltd

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmaceutical Science,Pharmacology

Reference116 articles.

1. Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians;Shimada;J Pharmacol Exp Ther,1994

2. In vitro inhibitory effects of troglitazone and its metabolites on drug oxidation activities of human cytochrome P450 enzymes: comparison with pioglitazone and rosiglitazone;Yamazaki;Xenobiotica,2000

3. Selective inhibition of human cytochrome P4502C8 by montelukast;Walsky;Drug Metab Dispos,2005

4. Amodiaquine clearance and its metabolism to N-desethylamodiaquine is mediated by CYP2C8: a new high affinity and turnover enzyme-specific probe substrate;Li;J Pharmacol Exp Ther,2002

5. 17 beta-estradiol hydroxylation catalyzed by human cytochrome P450 1A1: a comparison of the activities induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin in MCF-7 cells with those from heterologous expression of the cDNA;Spink;Arch Biochem Biophys,1992

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Application of a PBPK Model Incorporating the Interplay Between Transporters and Drug‐Metabolizing Enzymes for the Precise Prediction of Drug Toxicity;Transporters and Drug‐Metabolizing Enzymes in Drug Toxicity;2021-07-02

2. Co-Evolution between New Coronavirus (SARS-CoV-2) and Genetic Diversity: Insights on Population Susceptibility and Potential Therapeutic Innovations;Genetic Variation;2021-05-19

3. Genetic Polymorphisms Complicate COVID-19 Therapy: Pivotal Role of HO-1 in Cytokine Storm;Antioxidants;2020-07-18

4. Role of Genetic Variations in the Hepatic Handling of Drugs;International Journal of Molecular Sciences;2020-04-20

5. Lack of inhibition of CYP2C8 by saroglitazar magnesium: In vivo assessment using montelukast, rosiglitazone, pioglitazone, repaglinide and paclitaxel as victim drugs in Wistar rats;European Journal of Pharmaceutical Sciences;2019-03